I have said this recently and I'm saying it again. The next few months will be the culmination of the last 20 odd years in the clinic for SPL.
Forget Viraleze and Vivagel it's time for Dep to shine and if they can't raise a serious deal with one of the big pharma's then we'll be doomed.
If they pull a deal(s) like the previous ones with the pharmaceutical also rans then be prepared for more of the same.
Furthermore the pathway to market will also be critical for any sustainable sp growth. If it becomes necessary for these drugs to go into ph3 trials (nobody really knows this yet) then the wait will be 4 to 5 years at least before any dollars start to flow.
How is this all going to play out?
Regards AG's recent selling in significant numbers they have foiled any chance of some sp upwards movement. Thanks AG.
On the brighter side someone is buying!
SPL Price at posting:
14.0¢ Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)